At this stage, the implantation of an LVAD and its contribution to the regulation of the neuromodulatory effects of insulin on the heart is pivotal and may decelerate, stabilize, or even revert the deleterious cascades that have been activated in end-stage heart failure. This evidence concerns the gene INS and heart failure.